OPTIPHARM LIMITED

Company Registration Number:
12826028 (England and Wales)

Unaudited micro entity accounts for the year ended 31 August 2024

Period of accounts

Start date: 01 September 2023

End date: 31 August 2024

OPTIPHARM LIMITED

Contents of the Financial Statements

for the Period Ended 31 August 2024

Company Information - 3
Profit and Loss Account - 4
Balance sheet - 5
Footnotes to the Balance Sheet - 7

OPTIPHARM LIMITED

Company Information

for the Period Ended 31 August 2024




Registered office: 2
De Clere Way
Trelleck
Monmouth
GB-WLS
NP25 4NY
Company Registration Number: 12826028 (England and Wales)

OPTIPHARM LIMITED

Profit and Loss Account

for the Period Ended 31 August 2024


2024
£

2023
£
Turnover 0 0
Income from coronavirus (COVID-19) business support grants 0 0
Other Income 198 156
Cost of Materials ( 0 ) ( 0 )
Staff Costs ( 0 ) -
Depreciation and Writeoffs ( 0 ) -
Other charges ( 0 ) ( 17 )
Tax on Profit ( 49 ) ( 29 )
Profit or (Loss) for Period 149 110

OPTIPHARM LIMITED

Balance sheet

As at 31 August 2024


2024
£

2023
£
Current assets: 13,818 13,620
Net current assets (liabilities): 13,818 13,620
Total assets less current liabilities: 13,818 13,620
Accruals and deferred income: ( 98 ) ( 44 )
Total net assets (liabilities): 13,720 13,576
Capital and reserves: 13,720 13,576

OPTIPHARM LIMITED

Balance sheet continued

For the year ending 31 August 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 20 October 2024
And Signed On Behalf Of The Board By:

Name: James Baker
Status: Director

The notes form part of these financial statements

OPTIPHARM LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 August 2024

  • 1. Employee Information

    Average number of employees: 1

OPTIPHARM LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 August 2024

  • 2. Off balance sheet disclosure

    No